Pharmaceutical companies might think it a bit rich being asked to waive the patents on their Covid vaccines by Harry and Meghan, a couple who have rejected the concept of public service in an attempt to monetise their royal status. But let’s overlook the charge of hypocrisy and ask whether there really is any substance to Harry and Meghan’s charge that ‘ultra-wealthy’ pharmaceutical companies are holding up the vaccination of the developing world by refusing to surrender their intellectual property.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in